Intermediate CD14++CD16+ monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function
Open Access
- 22 August 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (8) , e0183670
Abstract
Transcatheter aortic valve replacement (TAVR) is the method of choice for patients with severe aortic valve stenosis, who are ineligible or at high risk for surgery. Though TAVR leads to a significant reduction in mortality, a notable amount of patients are re-hospitalized early after TAVR. Parameters or biomarkers predicting outcome are therefore needed to identify patients who benefit most. Specific monocyte subsets have been associated with cardiovascular diseases and were shown to possess prognostic value. Peripheral blood was drawn before and after transfemoral TAVR with the self-expanding CoreValve, Boston Lotus or the balloon-expanding Edwards Sapien prosthesis. Classical (CD14++CD16−), intermediate (CD14++CD16+) and non-classical (CD14+CD16++) monocyte subsets were determined by flow cytometry. Transthoracic echocardiography was performed before, early after as well as 3 months after the TAVR procedure. No significant differences in the absolute monocyte counts were found after TAVR. A significant decline in the intermediate monocyte population was though observed early after TAVR (pre 4.01±0.38%, post 2.803±0.34%, p≤0.05). Creatinine levels stayed stable after TAVR procedure and intermediate monocytes were associated with worse renal function. Monocyte decline was not related to changes in CRP-, noradrenaline, cortisol or aldosterone-levels. The amount of intermediate monocytes correlated with worse cardiac function and predicted the possibility to reach an improvement in NYHA functional class at 3 months after TAVR. A significant decline of intermediate monocytes occurs shortly after TAVR. High levels of intermediate monocytes were associated with worse cardiac function and predicted poor functional capacity, hinting at a possible prognostic value.Keywords
This publication has 45 references indexed in Scilit:
- Nomenclature of monocytes and dendritic cells in bloodBlood, 2010
- CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney diseaseEuropean Heart Journal, 2010
- Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood PressureHypertension, 2009
- β2-Adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytesImmunology Letters, 2005
- Adrenaline Inhibits Lipopolysaccharide-Induced Macrophage Inflammatory Protein-1α in Human Monocytes: The Role of β-Adrenergic ReceptorsAnesthesia & Analgesia, 2003
- Adrenaline Inhibits Lipopolysaccharide-Induced Macrophage Inflammatory Protein-1α in Human Monocytes: The Role of β-Adrenergic ReceptorsAnesthesia & Analgesia, 2003
- Comparison between New York Heart Association Classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1992
- ALTERATIONS OF β‐ADRENOCEPTORS ON HUMAN LEUKOCYTE SUBSETS INDUCED BY DYNAMIC EXERCISE: EFFECT OF PREDNISONEClinical and Experimental Pharmacology and Physiology, 1988
- Control of the Production of Oxygen Intermediates of Human Polymorphonuclear Leukocytes and Monocytes by B-Adrenergic ReceptorsJournal of Immunopharmacology, 1983
- Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failureThe American Journal of Cardiology, 1981